主持科研项目：
1．国家自然科学基金青年项目；2. 江苏省自然科学基金青年项目；3. 中国博士后基金面上项目；4. 江苏省博士后科研资助项目
代表性研究成果：
1. Yunjiang Zhou, Yaxin Chen, Yongwei Shi, Leyin Wu, Yingying Tan, Tao Li, Yigang Chen, Jiazeng Xia*, Rong Hu*. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway. Journal of Clinical Investigation. 2023 Feb 1;133(3):e158705.
2. Yunjiang Zhou*, Yunting Zou, Mei Yang, Shuang Mei, Xiaohao Liu, Huiyun Han, Chang-Dong Zhang, Miao-Miao Niu*. Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer. Journal of the American Chemical Society. 2022 Apr 27;144(16):7117-7128.
3. Yunjiang Zhou, Yaxin Chen, Yingying Tan, Rong Hu*, and Miao-Miao Niu*. An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy. ADV HEALTHC MATER. 2021 May;10(9):e2002197.
4. Yunjiang Zhou, Keke Wang, Yang Zhou, Tao Li, Mengdi Yang, Rui Wang, Yaxin Chen, Mengran Cao, and Rong Hu*. HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. Redox Biology. 2020 Jan;29:101390.
5. Yunjiang Zhou, Yang Zhou, Mengdi Yang, Keke Wang, Yisi Liu, Mingda Zhang, Yunjia Yang, Chenyu Jin, Rui Wang, and Rong Hu*. Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway. Redox Biology. 2019 Apr;22:101131.
联系方式：zyjcqmu@163.com